Filip Standaert – Managing Director Nordics, Johnson & Johnson

Filip Standaert outlines the significance of the Nordic cluster to J&J’s medical device operations in Europe, how the affiliate responded to the COVID-19 crisis, and the ways in which J&J is aiming to contribute to driving efficiencies within the Norwegian healthcare system.  
There is still change management to be done together with the [Norwegian] hospitals, but the situation is now changing rapidly, with more and more procurement officers, surgeons, and nurses open to the value approach
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report